Artificial Intelligence Beyond the Limits

Program - Main Topics

Artificial Intelligence (AI) has emerged as a transformative force in healthcare, pushing the boundaries of what was once considered possible in the field of medicine. Its potential to revolutionize healthcare is nothing short of extraordinary.

One of the most promising applications of AI in healthcare is in medical diagnostics. AI-powered systems can analyze vast amounts of medical data, including images from X-rays, MRIs, and CT scans, with unparalleled accuracy. These systems can detect diseases at earlier stages, leading to more effective treatments and improved patient outcomes. AI also aids in the early identification of diseases, such as cancer, by identifying subtle patterns that may go unnoticed by human eyes.

Treatment recommendations are another area where AI shines. Machine learning algorithms can analyze patient data, medical records, and clinical guidelines to suggest personalized treatment plans. This tailoring of therapies to individual patients can lead to more effective and efficient care, reducing the risks of adverse reactions and improving recovery rates.

In the realm of drug discovery, AI is accelerating the process of finding new treatments and medications. By sifting through vast datasets, AI algorithms can identify potential drug candidates and predict their efficacy, saving years of research time and costs.

Remote patient monitoring is yet another domain where AI has gone beyond limits. Wearable devices and sensors connected to AI systems can continuously collect and analyze patient data, providing real-time insights into health conditions. This proactive approach to healthcare allows for early intervention, reducing hospitalization rates and healthcare costs.

AI also plays a critical role in predictive analytics, helping healthcare providers anticipate patient needs. Predictive models can forecast disease outbreaks, patient admissions, and resource requirements, allowing hospitals and clinics to allocate resources efficiently and improve patient care.

Moreover, AI-powered chatbots and virtual assistants are enhancing the patient experience. They can answer medical queries, schedule appointments, and provide medication reminders, making healthcare more accessible and convenient.

Despite these incredible advancements, ethical and privacy concerns persist. Safeguarding patient data and ensuring transparency in AI decision-making processes are paramount. Regulations and ethical guidelines are being developed to address these issues and ensure responsible AI use in healthcare.

In conclusion, Artificial Intelligence has propelled healthcare beyond limits, revolutionizing diagnostics, treatment, drug discovery, and patient care. It’s ability to process vast amounts of data, make precise recommendations, and monitor patients remotely has the potential to save lives and improve the quality of care. As AI continues to evolve, it is essential to strike a balance between its remarkable capabilities and the ethical considerations that come with its use in healthcare. The future of medicine is undoubtedly intertwined with AI, and its potential to transform the industry is limitless

Rethinking the Innovation Pathway

Program - Main Topics

Rethinking the Innovation Pathway in Healthcare is imperative in today’s rapidly evolving landscape. Traditional healthcare innovation often faces challenges that hinder progress and limit accessibility. To truly transform the industry, we need a fresh approach.

Firstly, collaboration is key. Breaking down silos between healthcare providers, researchers, tech companies, and patients is essential. Open dialogue fosters creative solutions and accelerates the development of cutting-edge treatments and technologies.

Secondly, we must emphasize preventive care and personalized medicine. Shifting focus from reactive treatment to proactive health management can lead to better patient outcomes and reduced healthcare costs. Tailoring treatments to individual genetics and lifestyles holds tremendous potential.

Moreover, regulatory agencies need to adapt. Current processes are often slow and cumbersome, hindering the approval of innovative therapies. Streamlining regulations while ensuring safety is paramount to expedite the availability of groundbreaking treatments.

Additionally, data-driven decision-making is crucial. Harnessing the power of big data, AI, and machine learning can revolutionize diagnostics, treatment planning, and patient care. Predictive analytics can help healthcare providers intervene early and make more informed decisions.

Furthermore, patient engagement is central. Empowering individuals to actively participate in their healthcare fosters better outcomes. Telemedicine, wearables, and health apps can enhance communication and enable patients to take control of their well-being.

Investment in research and development should also be a priority. Allocating resources to long-term projects and breakthrough innovations can lead to medical discoveries that reshape the field.

Lastly, addressing healthcare disparities is essential. Innovation must prioritize equitable access to healthcare solutions for all communities, regardless of socioeconomic status, race, or geography.

In conclusion, rethinking the innovation pathway in healthcare is about breaking down barriers, embracing collaboration, and leveraging technology to provide accessible, personalized, and equitable care. By doing so, we can usher in a new era of healthcare that benefits everyone.

Digital Health Trends and Tendencies

Program - Main Topics

Digital health trends are revolutionizing healthcare systems worldwide. One of the most significant tendencies is the adoption of telemedicine. The COVID-19 pandemic accelerated this shift, making virtual consultations and remote monitoring commonplace. Telehealth offers convenience and access, particularly in rural or underserved areas.

Artificial Intelligence (AI) and Machine Learning (ML) are driving predictive analytics in healthcare. These technologies analyze vast amounts of patient data to predict disease outbreaks, personalize treatment plans, and improve diagnostics. AI-powered chatbots and virtual nurses also assist with patient education and medication reminders.

Wearable health technology is another noteworthy trend. Smartwatches and fitness trackers now monitor vital signs, track fitness goals, and even detect irregular heart rhythms. These devices empower individuals to take a proactive role in managing their health.

Blockchain is enhancing data security and interoperability. Patient records, securely stored on blockchain, can be accessed by authorized healthcare providers, streamlining care coordination and ensuring data integrity.

Genomics and personalized medicine are reshaping treatment approaches. Advances in DNA sequencing allow for tailored treatments based on a patient’s genetic profile. This precision medicine minimizes side effects and maximizes treatment efficacy.

Mental health receives increasing attention in the digital health landscape. Apps and online platforms offer therapy, stress management, and mindfulness tools, making mental healthcare more accessible.

Robotics and automation are transforming healthcare operations. Robots assist with surgeries, automate repetitive tasks, and even deliver medications within hospitals, reducing errors and improving efficiency.

The Internet of Medical Things (IoMT) connects medical devices, enabling real-time monitoring. This data-driven approach enhances early detection of health issues and enables prompt intervention.

Cybersecurity is paramount in this digital age. Healthcare systems must invest heavily in protecting patient data from cyberattacks and ensuring HIPAA compliance.

Collaboration between tech giants and healthcare institutions is driving innovation. Companies like Google and Apple are working on health-focused projects, while startups bring fresh ideas to the industry.

However, challenges persist. Privacy concerns and data ownership issues demand attention. Regulatory frameworks need to evolve to keep pace with technological advancements. And the digital divide must be addressed to ensure equitable access to digital health solutions.

In conclusion, digital health trends are reshaping healthcare, offering numerous benefits but also posing challenges. The future promises more personalized, accessible, and efficient healthcare, making it an exciting time for both patients and healthcare professionals.

Global Health & Climate Transition

Program - Main Topics

Global Health and Climate Transition are intricately interconnected challenges that our world faces today. Climate change, driven by human activities like burning fossil fuels and deforestation, is altering our planet’s environment at an alarming pace. This change is not just about rising temperatures; it encompasses a complex web of consequences that affect our health on a global scale.

One of the most immediate impacts of climate change on health is the increase in extreme weather events. More frequent and severe heatwaves, storms, and floods lead to injuries, displacement, and the spread of waterborne diseases. Rising temperatures also create fertile breeding grounds for disease-carrying vectors like mosquitoes, increasing the transmission of diseases such as malaria, dengue, and Zika.

The changing climate disrupts food systems and water sources, causing malnutrition and water scarcity. These issues disproportionately affect vulnerable populations, exacerbating global health inequalities. Additionally, the loss of biodiversity due to climate change can lead to the emergence of zoonotic diseases, like COVID-19, as humans come into closer contact with wildlife.

Air pollution, driven by the burning of fossil fuels, is a double-edged sword. It not only contributes to climate change but also directly harms human health. Poor air quality is linked to respiratory diseases, heart conditions, and premature death. The World Health Organization estimates that air pollution is responsible for around 7 million premature deaths each year.

However, there is hope on the horizon. The global community is increasingly recognizing the urgent need to address both climate change and global health. The Paris Agreement, signed in 2015, seeks to limit global warming and mitigate its impacts. Additionally, initiatives like the World Health Organization’s “Health for All” and the Sustainable Development Goals emphasize the importance of addressing climate-related health challenges.

The transition to a sustainable, low-carbon economy holds promise for improving global health. Investments in clean energy and transportation reduce air pollution and its associated health risks. Moreover, efforts to protect and restore ecosystems can help mitigate climate change while safeguarding biodiversity and reducing the risk of zoonotic diseases.

Education and awareness play a critical role in this transition. By understanding the link between climate change and health, individuals and communities can take steps to reduce their carbon footprint, adapt to changing conditions, and advocate for policies that prioritize both the environment and public health.

In conclusion, global health and climate transition are two sides of the same coin. Addressing one without the other is insufficient. Our planet’s health and our own are inextricably linked, and the path forward requires a holistic approach that recognizes this connection. By taking decisive action to combat climate change, protect biodiversity, and prioritize public health, we can build a more sustainable and resilient future for all.

Innovation towards a better life

Program - Main Topics

Innovation in healthcare is propelling the industry toward a brighter and more promising future. Over the past few decades, remarkable advancements have revolutionized the way we approach healthcare, benefiting both patients and providers alike.

One of the most significant innovations is the integration of technology into healthcare systems. Electronic Health Records (EHRs) have streamlined patient information management, reducing errors and improving coordination among healthcare professionals. Telemedicine, too, has gained prominence, providing convenient access to medical consultations and monitoring for individuals, especially in remote areas.

Artificial intelligence and machine learning are making waves in healthcare as well. These technologies enable predictive analytics, helping clinicians identify potential health issues before they escalate. AI-driven diagnostic tools are enhancing accuracy, while robots assist in surgeries, minimizing invasiveness and recovery times.

Personalized medicine is another critical innovation. Genetic profiling allows treatments to be tailored to an individual’s unique genetic makeup, increasing effectiveness and reducing adverse effects. Precision medicine is paving the way for targeted therapies in oncology and other fields.

The pharmaceutical industry is also embracing innovation. Vaccine development timelines have been significantly shortened, exemplified by the rapid development of COVID-19 vaccines. Moreover, 3D printing is revolutionizing drug manufacturing, enabling the creation of customized medications for specific patient needs.

Patient engagement has improved through mobile health apps and wearable devices. These tools empower individuals to take charge of their health, monitoring vital signs, physical activity, and medication adherence. The data generated can be shared with healthcare providers for more informed decisions.

Innovation extends to mental health as well. Teletherapy and mental health apps offer accessible resources for those in need. AI-powered chatbots and virtual therapists provide support and companionship, helping combat the mental health crisis.

Global collaboration has accelerated the pace of innovation, with researchers and organizations sharing data and findings for collective progress. Initiatives like open-source drug discovery and collaborative clinical trials are transforming the traditional healthcare landscape.

Despite these advancements, challenges remain. Data security and privacy concerns, as well as ethical dilemmas surrounding AI and genetics, need careful consideration. Additionally, the digital divide can limit access to healthcare innovation for some populations.

In conclusion, innovation in healthcare is propelling us toward a better future. Technology, personalized medicine, and global collaboration are transforming how we prevent, diagnose, and treat illnesses. While challenges persist, the potential for improved patient outcomes, reduced costs, and enhanced quality of life is undeniable. As we continue to push the boundaries of innovation, healthcare will become more accessible, efficient, and effective for all.

Global Health and Global Policies

Program - Main Topics

Global health and global policies are intrinsically intertwined in our interconnected world. The state of global health is a reflection of the effectiveness and inclusivity of international policies and agreements. As of my last knowledge update in September 2021, several key aspects deserve attention.

Firstly, the COVID-19 pandemic has showcased both the necessity and limitations of global policies in health. The rapid spread of the virus highlighted the need for coordinated international responses. Initiatives like COVAX aimed to ensure equitable vaccine distribution, emphasizing the importance of cooperation. However, vaccine distribution disparities and geopolitical tensions also exposed the challenges of implementing these policies.

Secondly, non-communicable diseases (NCDs) have become a global health crisis. Diseases like diabetes, heart disease, and cancer are no longer confined to wealthy nations; they affect people worldwide. Addressing NCDs requires comprehensive global policies that span healthcare access, prevention, and lifestyle changes.

Thirdly, the climate crisis is intricately linked with global health. Policies focused on reducing greenhouse gas emissions can have direct health benefits by decreasing air pollution and mitigating extreme weather events. Simultaneously, policies need to address the health challenges posed by climate change, such as the spread of vector-borne diseases and food security issues.

Furthermore, global policies must prioritize health equity. Health disparities persist across countries and within them. Access to healthcare, quality of healthcare, and social determinants of health like income and education profoundly influence individuals well-being. Global policies need to advocate for and implement strategies that reduce these disparities.

In addition, global health crises often disproportionately affect vulnerable populations, including refugees, migrants, and those living in conflict zones. Robust policies are required to ensure their access to healthcare and protection during crises.

Lastly, the role of technology in global health and policy cannot be understated. Innovations like telemedicine, data analytics, and vaccine development have the potential to transform healthcare delivery. However, policies must evolve to harness the benefits of technology while addressing issues like data privacy and equitable access.

In summary, global health and global policies are inseparable in our increasingly interconnected world. The COVID-19 pandemic underscored the need for effective international cooperation. However, challenges like NCDs, the climate crisis, health equity, and the impact of technology require ongoing attention and adaptable policies. The pursuit of a healthier, more equitable world necessitates constant collaboration and innovation in the realm of global health and policy-making.

Universal Coverage_ Myth or Reality

Program - Main Topics

The concept of universal healthcare coverage has been a topic of debate and aspiration for decades. It envisions a healthcare system where every individual, regardless of their socio-economic status, can access essential medical services without facing financial hardship. While this idea sounds noble and desirable, its realization is a complex and contentious issue, leading many to question whether universal coverage is a myth or a tangible reality.

Advocates of universal coverage argue that it’s not only a moral imperative but also an economic necessity. They contend that ensuring access to healthcare for all can lead to healthier populations, reduce overall healthcare costs in the long run, and enhance societal well-being. Countries like Canada, the United Kingdom, and several Nordic nations have implemented versions of universal healthcare, which they claim have improved the health of their citizens and reduced disparities.

However, critics raise valid concerns about the feasibility and sustainability of universal healthcare. One of the major hurdles is the cost. Providing healthcare for an entire population can be an enormous financial burden for governments. Taxpayers often worry about the potential increase in taxes needed to fund such a system. Additionally, there are worries about the quality and efficiency of care, as well as potential wait times for non-urgent procedures, which can be longer in systems with universal coverage.

Another challenge is the diversity of healthcare needs and expectations within a population. What works in one country may not be suitable for another. Cultural differences, healthcare infrastructure, and political ideologies can all impact the implementation and success of universal healthcare.

Moreover, there is a concern about the potential for rationing care. In systems with limited resources, tough decisions may have to be made about which treatments are funded, potentially leaving some patients without access to certain procedures or medications.

Despite these challenges, progress towards universal coverage has been made in many places. The Affordable Care Act in the United States expanded access to healthcare for millions, though it falls short of true universal coverage. Other countries have successfully navigated the complexities of universal healthcare by implementing various models that balance quality, accessibility, and cost.

In conclusion, the question of whether universal coverage in healthcare is a myth or reality is complex and multifaceted. While it is challenging to achieve in its purest form, it is not an unattainable ideal. Many countries have made strides towards providing healthcare for all, demonstrating that it is possible with the right policies and commitment. However, the road to universal coverage is fraught with financial, logistical, and ideological challenges that require careful consideration and adaptability to each nation’s unique circumstances. It is a goal worth pursuing, but one that requires ongoing evaluation and adjustment to ensure it remains a reality rather than a myth.

Health Policies_ Need for a New Generation of ideas

Program - Main Topics

Health policies play a crucial role in shaping the well-being of societies, and the need for a new generation of ideas in this field has never been more apparent. The challenges facing healthcare systems worldwide are multifaceted, from the rising costs of medical care to the inequities in access and the ever-evolving landscape of health threats. To address these complex issues, we must embrace innovative and forward-thinking approaches.

First and foremost, our health policies must prioritize prevention over treatment. The old adage “an ounce of prevention is worth a pound of cure” holds true. Promoting healthy lifestyles, encouraging vaccinations, and investing in early disease detection can reduce the burden on healthcare systems and improve overall public health. These strategies should be central to any new health policy framework.

Furthermore, the integration of technology is pivotal. Telemedicine, wearable health devices, and data analytics offer unprecedented opportunities to personalize healthcare, enhance diagnostics, and streamline care delivery. Embracing these innovations can lead to more efficient healthcare systems, greater patient engagement, and improved outcomes.

Health policies must also confront health inequalities head-on. Access to healthcare should not be determined by one’s socioeconomic status, race, or geographical location. A new generation of ideas should focus on reducing disparities in healthcare access and outcomes, ensuring that everyone has an equal opportunity to lead a healthy life.

The mental health crisis, exacerbated by the COVID-19 pandemic, deserves special attention. Mental health should no longer be stigmatized or overlooked in health policies. Comprehensive mental health services should be readily available, and policies should promote mental well-being as an integral part of overall health.

Another critical aspect is environmental health. Climate change and pollution have far-reaching health consequences. Policies should encourage sustainability, clean energy, and pollution control measures to safeguard public health for future generations.

In the face of emerging infectious diseases and global health threats, international collaboration and preparedness are paramount. New ideas in health policies should emphasize global cooperation in surveillance, early warning systems, and rapid response to pandemics.

Lastly, healthcare financing models should be reimagined. Universal healthcare coverage, innovative payment models, and cost-effective pharmaceutical pricing should be central to health policy discussions.

In conclusion, the need for a new generation of ideas in health policies is undeniable. These ideas should prioritize prevention, leverage technology, address health inequalities, prioritize mental health, promote environmental health, enhance global collaboration, and rethink healthcare financing. By embracing these principles, we can build a healthier and more resilient world for all.

Vaccines and new frontiers of life

In a world where emerging diseases continually threaten our global health, a new chapter is being written in the history of vaccines. The parallel session, “Vaccines and New Frontiers of Life,” explores the intricate interaction between science, innovation, and public health as we face unprecedented challenges. This parallel session delves into the rapid development of vaccines to combat the ever-evolving landscape of infectious diseases. From the groundbreaking mRNA technology utilized in COVID-19 vaccines to the tireless efforts of researchers and healthcare professionals on the front lines, we face the extraordinary endeavors of our time. However, with these breakthroughs comes controversy. “Vaccines and New Frontiers of Life” aims to debate the skepticism and misinformation surrounding vaccines, highlighting the importance of science-based decision-making and the battle against vaccine hesitancy. It highlights the voices of experts dedicated to dispelling myths and ensuring the public understands the significance of vaccination in safeguarding our collective well-being. As the world grapples with the ongoing challenges of emerging diseases, this session takes viewers on a journey through the triumphs, trials, and triumphs again in the realm of vaccines. It invites all the participants to reflect on vaccines’ critical role in our modern society and underscores the need for global cooperation in the face of these relentless threats. In this parallel session of the Global Heal Forum, we would like to explore the nexus between science, ethics, and public health, contributing to a poignant reminder of the resilience of the human spirit and the relentless pursuit of solutions to safeguard our future in an ever-changing world.

As novas fronteiras da Medicina Laboratorial

O futuro da medicina laboratorial já começou e assenta em significativos avanços tecnológicos que nos permitem ultrapassar novas fronteiras no domínio do diagnóstico. A genómica é o principal suporte do novo paradigma médico conhecido como Medicina de Precisão ou Medicina Personalizada, em que a definição do diagnóstico molecular de cada doente determina a terapêutica específica e individualizada para cada um. A oncogenómica, disciplina fundamental para o diagnóstico e tratamento de doenças oncológicas hereditárias ou adquiridas, é uma das áreas que mais beneficia e beneficiará deste avanço laboratorial.

Da mesma forma, a proteómica abriu novas fronteiras no diagnóstico laboratorial da Doença de Alzheimer (DA) no sangue periférico, numa fase muito precoce, confirmando as mais ligeiras suspeitas clínicas, mesmo quando outro tipo de exames nada revela ou é demasiado invasivo. Considerando a possibilidade da eficácia de novos medicamentos, já existentes ou em desenvolvimento, actuarem nas fases muito iniciais desta forma de demência, impedindo a sua evolução, urge a utilização de novos testes que permitam, no sangue periférico, medir determinadas proteínas, com altíssima sensibilidade e especificidade fazendo precocemente o diagnóstico da DA permitindo atuar eficazmente nesta doença, ultrapassando uma nova fronteira não só na medicina laboratorial mas, mais especificamente, na neurologia.

Data Science e a Interoperabilidade dos Dados

Data Science e interoperabilidade cobrem o cerne do desenvolvimento de tecnologia para a saúde. É a estrada de informação que abre caminho para a inovação. Os dados das organizações de saúde podem ajudar a melhorar o diagnóstico, novos tratamentos, atendimento ao paciente e serviços gerais. Iremos discutir em que ponto estamos nos dias de hoje e como podemos acelerar a adoção de tecnologia suportada por data science e pela interoperabilidade.

Cuidados Domiciliários: Novos Desafios e Oportunidades

Levar os cuidados de saúde a casa permite melhorar a experiência do cliente em termos do conforto pessoal, mas também no plano da segurança e da qualidade clínica, designadamente pela redução de eventos adversos evitáveis.

A hospitalização domiciliária à escala do SNS português está a revelar-se uma resposta essencial para a redução da demora média hospitalar, permitindo libertar meios e recursos que impulsionam a melhoria do acesso e dos tempos de resposta.

Os cuidados em casa constituem uma oportunidade de mercado substancial para os diferentes operadores dos setores público, privado e social, e uma excelente iniciativa para a criação de maior valor para todos os stakeholders do setor.

Fórum dos CEO

Esta sessão paralela visa melhorar a colaboração entre os stakeholders no sistema de saúde, incluindo entidades oficiais, prestadores de cuidados de saúde, indústria e cidadãos questão crucial para melhorar o acesso e a qualidade dos cuidados. O principal objetivo é estabelecer canais de comunicação entre todas as partes interessadas para facilitar a partilha de informações e a colaboração. Nesta sessão, procura-se uma visão partilhada que defina objetivos comuns para o sistema de saúde. Esses objetivos devem ter como prioridades o acesso, a eficiência e a qualidade dos cuidados para todos os cidadãos. O Forum discutirá a importância do alinhamento de políticas, regulamentos e incentivos com o objetivo geral de melhorar o acesso e a qualidade dos cuidados de saúde através da promoção de políticas que promovam a inovação e a eficiência. Este Fórum debaterá, igualmente, a importância da interoperabilidade e da partilha de dados entre prestadores de cuidados de saúde, entidades pagadoras e parceiros da indústria permitindo uma compreensão mais abrangente das necessidades dos cidadãos e dos resultados dos cuidados de saúde. O debate também deverá ser centrado na adoção de tecnologias de saúde, como a saúde digital para melhorar a coordenação e a acessibilidade dos cuidados. Também será discutida a importância da implementação de incentivos baseados no desempenho para que os prestadores de cuidados de saúde e as organizações promovam cuidados de saúde de alta qualidade e melhores resultados para os utentes. Em síntese, esta sessão paralela tem como objetivo incentivar os esforços de parceria que se concentram na inovação e na melhoria dos cuidados de saúde, uma vez que melhorar a colaboração entre as partes interessadas no sistema de saúde é um processo contínuo que requer compromisso, flexibilidade e uma abordagem centrada no cidadão. Trabalhando em conjunto e implementando estas estratégias, será possível fazer progressos significativos na melhoria do acesso e da qualidade dos cuidados de saúde para todos os cidadãos.

Innovation Promoting Inclusion: Hearing Health What’s the Future.

Is a symposium that will explore the future of hearing health. The symposium aims to promote innovation, inclusion, and accessibility in hearing healthcare. The symposium will feature experts in the field of audiology, hearing technology, and public health. They will discuss the latest research, technologies, and policies related to hearing health. 

The symposium will also provide a platform for networking and collaboration among professionals, researchers, and advocates in the field.

Health & the Challenge of Quality

This session aims to provide a comprehensive understanding of key concepts related to whole system quality, leading for quality, and the future of quality on a global scale. It will facilitate discussions on interconnected dimensions of quality, such as leadership, integration, equity, digital advancements, and environmental sustainability.

Realising the Full Potential of Women’s Health and Well-being

Why do women, despite taking more care of their health, have a higher prevalence of disease and rend to be seen as fragile and weak?

Join us at a study presentation that aims to awaken consciences and demystify preconceptions about women’s health.

Inscreva-se na Lista de espera

Por favor preencha a informação abaixo para ficar inscrito na lista de espera. Se surgir disponibilidade, entraremos em contacto.

Join Waiting List

Please fill in the information below to join our Waiting List, and in the event of openings, we will get in touch with you.

Isabel Furtado

Administradora do Grupo TMG

Licenciada em Economia pela Universidade de Manchester, UK.

Administradora do Grupo TMG.  CEO da TMG Automotive e Administradora da HaMinGi, parceria industrial na China. 

Presidente da COTEC Portugal até 2022, atualmente membro da direção. Vice presidente da ATP. Presidente do Conselho da Administração do CEIIA, membro do Conselho Curadores da Universidade do Minho e do Governing Committee do MIT- Portugal.

Sessão: 29 Setembro - 10:00

Inovação, Ambiente e Sustentabilidade


Sessão: 30 Setembro - 11:30

Fórum dos CEO

Um painel que visa debater a ética da responsabilidade para a ação e cumprimento da sua missão essencial, no quadro globalizado em que o saber e a pessoa dependente constitui o escopo do desenvolvimento e da segurança, para criar confiança e qualidade de vida. O sustentáculo da cidadania pela democracia sanitária vai discutir-se da biomedicina aos seguros, da informação à gestão e investigação, num sistema de sinergias das potencialidades da tecnologia e ciência… Para um novo contrato social que a Saúde Global impõe.

Isabel Furtado

Administrator of the TMG Group

Graduated in Economics from the University of Manchester, UK.

Administrator of the TMG Group. CEO of TMG Automotive and Administrator of HaMinGi, an industrial partnership in China.

President of COTEC Portugal until 2022, currently member of the board. Vice president of ATP. President of the Board of Directors of CEIIA, member of the Board of Trustees of the University of Minho and of the Governing Committee of MIT-Portugal.

Session: 29 Sept - 10:00

Innovation, Environment and Sustainability


Session: 30 Sept - 11:30

CEO's Forum

A panel that aims to debate the ethics of responsibility for action and the fulfilment of its essential mission, in a globalized framework in which knowledge and the dependent person constitutes the scope of development and security, in order to create confidence and quality of life. The support of citizenship through health democracy will be discussed from biomedicine to insurance, from information to management and research, in a system of synergies of the potential of technology and science… For a new social contract that Global Health requires.

Joana Ascensão


Porto, Portugal · Jornalista · Expresso; ex jornalista do Observador,

Reportagem expresso 11/08/23 “O amor de dois casais levou a um raro transplante internacional de rins

18/01/2023 — A jornalista Joana Ascensão, do semanário Expresso, venceu o Grande Prémio Jornalismo Jovem, com a reportagem “Filhos Únicos da Terra”.

14/11/2022 O segundo premio da Sociedade Portuguesa de Psiquiatria e Saúde Mental foi concedido à reportagem “O Cancro não tem Sexo” da jornalista Joana Ascensão (Expresso). 

02/12/2019 Renascença, Prémio Nacional de Jornalismo de Inovação, categoria de Audiovisual, com a reportagem “Os incêndios matam abelhas. Isso afeta-nos mais do que pensa”.

Sessão: 29 Setembro - 14:30

O Futuro da Transplantação

O transplante é uma área da medicina que teve avanços significativos nos últimos anos, e apresenta um  promissor. Com a pesquisa e desenvolvimento em curso, espera-se que mais órgãos e tecidos fiquem disponíveis para transplante, e as taxas de sucesso desses procedimentos continuem a melhorar. Além disso, é provável que os avanços na tecnologia e nas técnicas tornem os procedimentos de transplante menos invasivos e mais eficientes, reduzindo o tempo de recuperação dos doentes. No geral, o futuro do transplante é uma grande promessa para aqueles que precisam de procedimentos que salvam vidas.

Joana Ascensão


Porto, Portugal · Journalist · Express; former Observer journalist,

Report express 11/08/23 “The love of two couples led to a rare international kidney transplant

18/01/2023 — Journalist Joana Ascensão, from the weekly Expresso, won the Grande Prêmio Jornalismo Jovem, with the report “Filhos Únicos da Terra”.

11/14/2022 The second prize of the Portuguese Society of Psychiatry and Mental Health was awarded to the report “Cancro não tem Sexo” by journalist Joana Ascensão (Expresso).

12/02/2019 Renascença, National Prize for Innovation Journalism, Audiovisual category, with the report “Fires kill bees. It affects us more than you think”.

Session: 29 Sept - 14:30

The Future of Transplantation

Transplantation is an area of medicine that has seen significant advancements in recent years, and the future of this field looks promising. With ongoing research and development, it is expected that more organs and tissues will become available for transplantation, and the success rates of these procedures will continue to improve. Additionally, advancements in technology and techniques are likely to make transplantation procedures less invasive and more efficient, reducing recovery times for patients. Overall, the future of transplantation holds great promise for those in need of life-saving procedures.

Isabel Vaz

CEO Luz Saúde

É licenciada em Engenharia Química pelo Instituto Superior Técnico (1990) e tem um Master of Business and Administration (MBA) pela Universidade Nova de Lisboa (1994). Após a licenciatura, iniciou a sua vida profissional como investigadora no Instituto de Biologia Experimental e Tecnológica (IBET). Foi Engenheira de Projeto Fabril no Grupo Atral Cipan. Em 1992, ingressou na McKinsey, empresa de consultadoria estratégica de alta direção, onde foi senior consultant durante sete anos, participando em projectos essencialmente na área da banca e seguros. Desde 1999, é Presidente da Comissão Executiva do Grupo Luz Saúde, liderando mais de 13 mil colaboradores em 30 unidades de saúde, entre as quais o Hospital da Luz, em Lisboa. Desde 2012, o Grupo que lidera gere também, em regime de Parceria Público-Privada, um hospital público – o Hospital Beatriz Ângelo, em Loures. Foi membro do Conselho de Faculdade da Nova School of Business and Economics da Universidade Nova de Lisboa. E membro do International Advisory Board do The Lisbon MBA, da mesma Faculdade. Foi ainda membro do Conselho Geral da Universidade de Lisboa. Nos últimos anos, tem realizado regularmente conferências sobre gestão em saúde, liderança, recursos humanos e sustentabilidade financeira dos sistemas de saúde, a convite de diversas universidades e outras instituições. Em 2015, recebeu o prémio do Jornal de Negócios «Excellens Oeconomics», como melhor gestora do ano em Portugal. Em 2017, recebeu o Prémio Maria de Lourdes Pintasilgo 2017, atribuído pelo Instituto Superior Técnico (IST) a antigas alunas que se distinguiram no seu percurso profissional e social.

Sessão: 30 Setembro - 11:30

Fórum dos CEO

Um painel que visa debater a ética da responsabilidade para a ação e cumprimento da sua missão essencial, no quadro globalizado em que o saber e a pessoa dependente constitui o escopo do desenvolvimento e da segurança, para criar confiança e qualidade de vida. O sustentáculo da cidadania pela democracia sanitária vai discutir-se da biomedicina aos seguros, da informação à gestão e investigação, num sistema de sinergias das potencialidades da tecnologia e ciência… Para um novo contrato social que a Saúde Global impõe.

Isabel Vaz

CEO Luz Saúde

She holds a degree in Chemical Engineering from Instituto Superior Técnico (1990) and a Master of Business and Administration (MBA) from Universidade Nova de Lisboa (1994). After graduation, she began her professional life as a researcher at the Institute of Experimental and Technological Biology (IBET). She was a Factory Project Engineer at Grupo Atral Cipan. In 1992, he joined McKinsey, a senior management strategic consulting firm, where he was a senior consultant for seven years, participating in projects mainly in the area of banking and insurance. Since 1999, he has been Chairman of the Executive Committee of the Luz Saúde Group, leading more than 13,000 employees in 30 health units, including the Hospital da Luz in Lisbon. Since 2012, the Group he leads also manages, under a Public-Private Partnership, a public hospital – the Beatriz Ângelo Hospital, in Loures. He was a member of the Faculty Council of the Nova School of Business and Economics of the Universidade Nova de Lisboa. He is a member of the International Advisory Board of The Lisbon MBA, from the same Faculty. He was also a member of the General Council of the University of Lisbon. In recent years, it has regularly held conferences on health management, leadership, human resources, and financial sustainability of health systems, at the invitation of several universities and other institutions. In 2015, she received the award of the Jornal de Negócios «Excellens Oeconomics», as the best manager of the year in Portugal. In 2017, she received the Maria de Lourdes Pintasilgo 2017 Prize, awarded by Instituto Superior Técnico (IST) to former students who have distinguished themselves in their professional and social career.

Session: 30 Sept - 11:30

CEO's Forum

A panel that aims to debate the ethics of responsibility for action and the fulfilment of its essential mission, in a globalized framework in which knowledge and the dependent person constitutes the scope of development and security, in order to create confidence and quality of life. The support of citizenship through health democracy will be discussed from biomedicine to insurance, from information to management and research, in a system of synergies of the potential of technology and science… For a new social contract that Global Health requires.

Joana Barbosa

Partner at Return on Ideas

She is dedicated to the production and dissemination of knowledge about consumers and citizens produced by Return on Ideas, including the SAÚDES project, by Médis, in whose investigations she has been involved. She takes charge of investigations, research, editing & information design.

Session: 29 Sept - 14:30

Realising the Full Potential of Women's Health and Well-being

Joana Barbosa

Partner at Return on Ideas

Dedica-se à produção e disseminação de conhecimento sobre consumidores e cidadãos produzido pela Return on Ideas, incluindo o projecto SAÚDES, da Médis, em cujas investigações tem estado envolvida. Assume a direcção de investigações, research, edição & design de informação.

Sessão: 29 Setembro - 14:30

Entender todo o potencial da saúde e bem-estar da mulher

Ricardo Valente

City Councilor for Economy, Employment and Entrepreneurship and City Councilor for Finance, Economic Activities and Inspectorate.

Ricardo Valente is City Councilor for Economy, Employment and Entrepreneurship and City Councilor for Finance, Economic Activities and Inspectorate. He is Board Member of Porto Vivo – Porto Urban Rehabilitation Society.

Mr. Valente is also a professor at the School of Economics and Management of the University of Porto and at PBS – Porto Business School.

Ricardo Valente was City Councilor for Economy, Tourism and Commerce and City Councilor for European Funds (2017 – 2021), City Councilor for Economic and Social Development (2016 – 2017), and Non-executive City Councilor (2013 – 2016). He was also the President of Porto Convention & Visitors Bureau (2018 – 2020), President of the Board of GO Porto – Municipal Management and Works Company (2016 – 2017), and Member of the National Bidding Commission for the Relocation of the European Medicines agency (2017).

From 1992 to 2016, Mr. Valente worked in risk management consulting, capital markets (as director and board member of brokerage firms), asset management (as CEO of one of the largest independent asset management firms in Portugal), investment banking (as member of the board of a bank), and was also an investment consultant.

Mr. Valente has a Master’s degree in finance and a MBA in finance from the Catholic University of Lisbon, and a degree in Economics from the University of Porto.

Mr. Valente is the author of several books on risk management.

Session: 29 Sept - 14:30

Citizen Forum

Para participar deverá inscrever-se utilizando o seguinte código:


Para efetuar o seu registo, basta clicar aqui e utilizar o Código de Convite fornecido durante o processo.

To participate, you must register using the following code:


To proceed with your registration, simply click here and use the provided Invitation Code during the process

[ninja_form id="1" ]

Gisela Lameira

Architect and researcher at the Centre for Studies in Architecture and Urbanism of the Faculty of Architecture of the University of Porto

Gisela Lameira (Viseu, 1978) is an architect and a contract researcher at the Centre for Studies in Architecture and Urbanism of the Faculty of Architecture of the University of Porto (FAUP–CEAU, Portugal), and holds a PhD in architecture from FAUP (2017). Her research interests include the study of architecture and urban theory and history, specifically the genesis and transformation of multifamily housing. She worked as a research fellow on the FCT project “Mapping Public Housing: A Critical Review of the State‐Subsidised Residential Architecture in Portugal (1910–1974),” hosted by FAUP/ CEAU [P2020-PTDC/CPC-HAT/1688/2014], and is currently undertaking research for the research projects “Ageing in Place/Architecture4Ageing”and “Housing Think Tank: knowledge integration on multi-family residential buildings” (HoTT),” at FAUP. Between 2019 and 2022 he taught History of Contemporary Architecture at FAUP. Her scientific production is available at:

Session: 29 Sept - 10:00

Architecture, Health and Wellness

As stated by the United Nations, it is obvious that our future is urban and, accordingly, for the World Health Organization that health should be prioritized in urban and territorial planning, in order to incorporate it into decision-making and thus favouring “age-friendly cities”. For the next generation of elders who wish to keep participating actively in society, shared and social spaces are crucial for both physical and mental health. Sharing and generational diversity are essential components for wellbeing, underscoring the psychosocial advantages of the community dimension. With a wide variety of collective, self-organized and participatory forms of housing, the concept of collaborative housing encompasses many forms of self-organized housing projects, created with a collective effort, in which residents have access to generous shared spaces with a variety of uses as compensation for a minimal amount of private space. The new Basic Housing Law in Portugal already provides for collaborative housing as a form of access to permanent housing, which will certainly arouse great interest to all those concerned with Architecture, Health and Wellness.


João Breda

Diretor do Gabinete de Atenas da OMS para a Segurança e Qualidade dos Cuidados de Saúde & Conselheiro Especial do Diretor Regional da OMS

Dr. João Breda é Diretor do Gabinete de Atenas da OMS para a Segurança e Qualidade dos Cuidados de Saúde e Conselheiro Especial do Diretor Regional da OMS para a criação de Gabinetes Sub-Regionais.

Antes de se mudar para a Grécia, João Breda assumiu cargos de liderança da OMS em Copenhaga (Dinamarca) durante sete anos e em Moscovo (Federação Russa) durante quatro anos. O recém-criado Centro de Excelência de Atenas tem como objetivo melhorar a segurança e qualidade dos cuidados de saúde dos doentes a nível nacional, visando reduzir desigualdades ao promover a liderança e inovação na saúde.

Até 2021, dirigiu o Gabinete Europeu da OMS para a Prevenção e Controlo das Doenças Não Transmissíveis (DNT), parte integrante do Gabinete Regional da OMS para a Europa. Lançado em 2014, este Gabinete é um marco importante no compromisso de combater as DNT na Região Europeia da OMS. Liderado pelo Dr. Breda, o Gabinete das DNT prestou apoio a 53 Estados-Membros da Região Europeia da OMS, com abordagens específicas a nível da população, com o objetivo de assegurar uma redução do risco de DNT e a descida global da mortalidade prematura. Em 2019, a equipa que liderava recebeu o Prémio de Excelência atribuído por Dr. Tedros Adhanom Ghebreyesus, Diretor-Geral da OMS, que reconhece o contributo excecional para a Organização, com ganhos e conquistas tangíveis.

João Breda tem um doutoramento em Ciências do Consumo Alimentar e Nutrição pela Universidade do Porto, um master em Gestão pela EU Business School de Barcelona, um master em Saúde Pública e uma licenciatura em Ciências da Nutrição.

Sessão: 30 Setembro - 16:50

Políticas de Saúde: a Urgência de Novas Ideias

Para melhorar a eficiência e eficácia dos sistemas de saúde, para prevenir doenças, promover a qualidade de vida… há um mundo de possibilidades e oportunidades que podem ser consideradas nas políticas de saúde. O momento de fazer a mudança é agora!

Sessão: 30 Setembro - 9:30

A nutrição é determinante na esperança de vida, mas também nos anos de vida saudável. O avanço da ciência transporta-nos para uma nova era da nutrição com decisivos contributos para a sustentabilidade do sistema de saúde e do sistema alimentar. De que estamos à espera para agir?

Carlos Carreiras

Presidente da Câmara Municipal de Cascais


Sessão: 29 Setembro - 09:00

Sessão de Abertura

Global Health Forum Registration - Invitation Code

Hello, I would like to receive the Invitation code for Global Health Forum 2023.

João Breda

Head of the WHO Athens Quality of Care and Patient Safety Office & SPECIAL ADVISER for the WHO Regional Director

Dr João Breda is the Head of the new Athens Quality of Care Office and Special Adviser of WHO Regional Director for the establishment of Sub-Regional Offices. Before moving to Greece João has been posted in WHO Senior Positions in Copenhagen (Denmark) for seven years and Moscow (Russian Federation) for four years. The newly established Athens Centre of Excellence aims to improve quality of care and patient safety at country level and focusing on reducing inequalities while promoting health innovation and leadership.
Until 2021 he Headed the WHO European Office for the Prevention and Control of Noncommunicable Diseases (NCD Office), which is an integral part of the WHO Regional Office for Europe. Launched in 2014, the NCD Office marked an important milestone in the commitment made to combatting NCDs in the WHO European Region. Led by Dr Breda, the NCD Office provided support to 53 Member States in the WHO European Region based on population-level, targeted approaches to ensure a reduction in NCD risk, an overall decline in premature mortality. In 2019, the team he was leading was given an Award of Excellence announced by Dr Tedros Adhanom Ghebreyesus, WHO Director-General, which acknowledges the exceptional contribution to the Organization, tangible gains, and achievements.
Dr João Breda is a PhD in Food Consumption & Nutritional Sciences by Porto University, a Master of Business Administration by the EU Business School in Barcelona, a Master’s in Public Health and initially graduated in Nutritional Sciences.

Session: 30 Sept - 16:50

Health Policies: Need for a New Generation of Ideas

To improve the efficiency and effectiveness of healthcare systems, to prevent disease, to promote quality of life… there is a world of possibilities and opportunities that can be factored in in healthcare policies. The time to make the change is now!

Session: 30 Sept - 9:30

Nutrition & Health

Nutrition is crucial in life expectancy, but also in years of healthy life. The advancement of science takes us into a new era of nutrition with decisive contributions to the sustainability of the health system and the food system. What are we waiting for to act?